Journal of Ovarian Research (May 2024)
Correction: A methylation‑ and immune‑related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance
- Lu Chen,
- Wujiang Gao,
- Li Lin,
- Chunli Sha,
- Taoqiong Li,
- Qi Chen,
- Hong Wei,
- Meiling Yang,
- Jie Xing,
- Mengxue Zhang,
- Shijie Zhao,
- Wenlin Xu,
- Yuefeng Li,
- Lulu Long,
- Xiaolan Zhu
Affiliations
- Lu Chen
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Wujiang Gao
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Li Lin
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Chunli Sha
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Taoqiong Li
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Qi Chen
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Hong Wei
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Meiling Yang
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Jie Xing
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Mengxue Zhang
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Shijie Zhao
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Wenlin Xu
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- Yuefeng Li
- Medical School, Jiangsu University
- Lulu Long
- Oncology Department, Affiliated People’s Hospital of Jiangsu University
- Xiaolan Zhu
- Reproductive Medicine Center, The Fourth Affiliated Hospital of Jiangsu University
- DOI
- https://doi.org/10.1186/s13048-024-01438-9
- Journal volume & issue
-
Vol. 17,
no. 1
pp. 1 – 4
Abstract
No abstracts available.